BLACKSOLVENT STARTUP NEWS | 19.10.26
Chips, Clouds and Corporate Cards
This was the week the AI trade moved down the stack and into the finance department. A US$1.5 billion Series E for Jim Keller’s Tenstorrent, a US$750 million cheque for AI cloud Modal at a US$15.75 billion valuation, US$125 million for Salience Labs’ photonic switches and US$65 million for Mueon’s modular compute — investors kept paying for the silicon and the servers that AI actually runs on. Then Ramp topped them all, raising US$1.85 billion at a US$60 billion valuation to turn the corporate card into an AI-powered finance stack. Around those headliners, AI assistants, AI security and AI-native insurance minted fresh unicorns, while biotech and healthcare quietly put more than US$500 million to work. The message for founders: own the compute, or own the workflow where money gets spent.
Across the 22 disclosed financings below, companies raised approximately US$6.08 billion (excluding Otter.ai’s US$320 million in repayable, non-equity growth financing). That total is led by Ramp’s US$1.85 billion primary round and Tenstorrent’s US$1.5 billion Series E. It is a selected, disclosure-based snapshot of rounds announced between October 12 and 20, 2026 — not a measure of all global venture activity. For context, Crunchbase News’ weekly Top 10 for U.S. companies (October 10–16) ran from US$750 million down to US$60 million — a noticeably thinner top end than the prior week — while Tech.eu tracked more than 65 European tech deals worth over €1.8 billion.
Ramp Raises US$1.85 Billion at a US$60 Billion Valuation
BY BLACKSOLVENT NEWS
New York-based Ramp raised US$1.85 billion in a primary financing round led byDragoneer Investment Group, valuing the company at US$60 billion. Thrive Capital, Founders Fund, Sands Capital and Avenir Growth co-led the round, with Fidelity, T. Rowe Price, GIC, Coatue, General Catalyst, Lightspeed and others participating. The round was announced on October 15.
Founded in 2019, Ramp provides corporate cards, expense management, accounts payable and procurement software, and says annualised revenue has topped US$2 billion across more than 85,000 business customers. Why it matters: this is the largest disclosed round of the week by a distance, and it shows that investors will still pay megadeal prices for software embedded in how companies spend money — especially as Ramp extends financial controls to AI tokens and model spend. At this scale, the next milestone looks more like an IPO than another private round.
Tenstorrent Raises US$1.5 Billion Series E to Challenge AI-Chip Incumbents
BY BLACKSOLVENT NEWS
Santa Clara-based Tenstorrent raised US$1.5 billion in a Series E at a US$6.2 billion post-money valuation, more than doubling its December 2024 mark. The round was led by Trace Capital and Innovation X, with participation from ARK Invest, Fidelity, Morgan Stanley, T. Rowe Price, SanDisk, Cadence Ventures, Eclipse, Maverick Silicon and XTX Markets, among others.
Led by veteran chip architect Jim Keller, Tenstorrent builds AI processors, Galaxy server systems and RISC-V CPUs, and licenses its chip IP to companies designing their own silicon. Why it matters: an open, licensable architecture is a direct pitch to sovereign-compute projects and hyperscalers that want an alternative to closed ecosystems. The capital funds volume manufacturing — now Tenstorrent has to turn technical credibility into shipments.
Modal Raises US$750 Million Series D as Revenue Run Rate Passes US$1 Billion
BY BLACKSOLVENT NEWS
New York-based Modal Labs raised US$750 million in a Series D led by Accel, withKleiner Perkins and existing investors participating, at a US$15.75 billion valuation — more than triple its valuation from May.
Modal runs serverless cloud infrastructure for AI inference, training and agent sandboxes on capacity rented from more than 20 cloud providers, and says its annualised revenue has passed US$1 billion. Why it matters: agents need somewhere safe and elastic to run code, and Modal’s Sandboxes product already drives nearly a third of revenue. The new money funds reinforcement-learning and post-training services — moving Modal further up the AI development workflow.
CMR Surgical Lands About US$400 Million Strategic Investment From Stryker
BY BLACKSOLVENT NEWS
Cambridge, UK-based CMR Surgical agreed a strategic preferred equity investment of approximately US$400 million (£300 million) from medtech giant Stryker, announced on October 12 and subject to customary closing conditions. The deal gives Stryker anexclusive option to acquire 100% of CMR in the future and makes it the exclusive U.S. sales agent for the Versius surgical robot.
CMR’s Versius is a modular, soft-tissue surgical robot designed to slot into existing operating-room workflows. Why it matters: this is not a classic venture round — it is a corporate cheque with an acquisition option attached — but it gives one of Europe’s best-known robotics companies the U.S. distribution it has long needed, and marks Stryker’s entry into soft-tissue robotics.
Otter.ai Secures US$320 Million in Growth Financing From General Catalyst
BY BLACKSOLVENT NEWS
AI meeting-notes company Otter.ai closed US$320 million in growth financing fromGeneral Catalyst’s Customer Value Fund, announced on October 20. Reuters reports the financing is repayable rather than equity, meaning no shareholder dilution. (It is listed here but not counted in this roundup’s total.)
Otter makes an AI notetaker and conversational knowledge platform with more than 40 million users, and plans to double or triple its sales and marketing budget to push into enterprise. Why it matters: revenue-based growth capital is becoming a real alternative to a priced round for AI companies with predictable subscription revenue — a structure more founders will weigh as valuations get stretched.
Icon Raises US$200 Million Series D for Robotic Construction
BY BLACKSOLVENT NEWS
Austin-based Icon raised a US$200 million Series D co-led by Baillie Gifford and funds managed by BlackRock, bringing total funding to about US$700 million at a reportedUS$1.4 billion valuation.
Icon builds robotic construction systems best known for 3D-printed homes, and is bringing Titan, its next-generation system, to market; the company says it is on pace for 4x revenue growth in 2026. Why it matters: housing shortages and labour gaps are making construction automation an infrastructure story, not a novelty. Two of the world’s largest asset managers backing Icon signals belief that printed buildings can scale.
Soufflé Therapeutics Raises US$135 Million Series B for RNA Medicines
BY BLACKSOLVENT NEWS
Boston-based Soufflé Therapeutics closed an oversubscribed US$135 million Series Bled by Juvia Group, alongside an expanded syndicate of investors.
Co-founded by MIT’s Bob Langer, Soufflé develops RNA therapies that reach tissues beyond the liver, with lead programmes aimed at muscle disease, heart failure and metabolic conditions. Why it matters: delivering RNA drugs outside the liver is one of the field’s hardest unsolved problems. The round funds the move into clinical development, where Soufflé must show its delivery platform works in patients.
Nouscom Raises €120 Million Series D for Cancer-Prevention Immunotherapy
BY BLACKSOLVENT NEWS
Basel-based Nouscom raised €120 million (approximately US$135 million) in an oversubscribed Series D co-led by M Ventures and Revelation Partners, with new investors Angelini Industries, the European Investment Bank and Neva SGR, and existing backers including 5AM Ventures, Bpifrance, EQT Life Sciences and Versant Ventures.
Nouscom is developing NOUS-209, an experimental immunotherapy designed to prevent cancer in people with Lynch syndrome, an inherited condition that raises colorectal cancer risk. Why it matters: cancer interception is a largely untapped category. The money funds a global registration-enabling study — the test of whether early signals translate into fewer cancers.
Salience Labs Raises US$125 Million Series B for Photonic AI Networking
BY BLACKSOLVENT NEWS
Oxford-based Salience Labs completed an oversubscribed US$125 million Series B led by Bullhound Capital, with participation from AMD Ventures, Intel Capital, SBI Group and Hudson River Trading, among others.
Salience builds silicon-photonics optical circuit switches that connect thousands of GPUs inside AI data centres, and recently demonstrated a 64-port all-optical switch. Why it matters: as AI clusters grow, moving data between chips is as much of a bottleneck as the chips themselves. Light-based switching promises lower power and latency — and the funding scales volume manufacturing and a Silicon Valley expansion.
Town Raises US$108 Million Series B, Hitting Unicorn Status Four Months After Launch
BY BLACKSOLVENT NEWS
San Francisco-based Town raised a US$108 million Series B co-led by Forerunner Ventures and Menlo Ventures, with Andreessen Horowitz, Serena Ventures and First Round Capital participating, at a unicorn valuation. It has now raised at least US$160 million.
Founded by former Plaid CTO Jean-Denis Greze, Town gives every employee an AI assistant — a “Townie” — that connects to email, calendars and core work systems, and can coordinate with colleagues’ assistants. Why it matters: reaching a billion-dollar valuation four months after public launch shows how quickly capital chases visible enterprise adoption. The challenge is standing out in a crowded assistant market where the largest labs are shipping similar features.
Estuary Biotherapeutics Launches With US$103 Million for Kidney Gene Therapies
BY BLACKSOLVENT NEWS
Menlo Park-based Estuary Biotherapeutics emerged from stealth with US$103 million, including a US$93 million Series A led by RA Capital Management and US$10 million in previously undisclosed seed funding. Deep Track Capital, Biogen New Ventures and UPMC Enterprises also participated.
Estuary develops kidney-targeted gene therapies, starting with autosomal dominant polycystic kidney disease (ADPKD). Why it matters: the kidney has been hard to reach with gene therapy, and ADPKD has few disease-modifying options. A nine-figure launch gives Estuary the runway to take two programmes into the clinic.
Labelbox Raises More Than US$100 Million Series E to Train Frontier AI
BY BLACKSOLVENT NEWS
San Francisco-based Labelbox raised more than US$100 million in Series E financing —including equity and a credit facility — at a US$1.25 billion pre-money valuation, led by Infinitum Partners, with Wipro Ventures and Andreessen Horowitz participating.
Labelbox began in data labelling and now powers reinforcement learning for frontier models and managed AI agents for enterprises. Why it matters: as models plateau on public data, the human-expert feedback loops that make them better are becoming a premium input. Labelbox says it is profitable — a rare trait in the AI tooling layer.
Blackwall Raises US$100 Million Series C as Bot and Agent Traffic Explodes
BY BLACKSOLVENT NEWS
Estonia-based Blackwall raised a US$100 million Series C at a US$2.2 billion valuation, four times its 2025 mark, led by AVP, with existing investors Dawn Capital, MMC Ventures and Tera Ventures participating.
Blackwall sells web traffic security tools through hosting, cloud and managed-service providers, helping them separate real visitors and legitimate AI agents from malicious bots. Why it matters: AI agents are rewriting what “traffic” means on the internet. Whoever decides which agents get in — and on what terms — sits on a valuable control point as agentic commerce grows.
Suki Raises US$90 Million Series E to Scale Healthcare AI Agents
BY BLACKSOLVENT NEWS
Redwood City-based Suki raised US$90 million in Series E financing from backers including Healthier Capital and Crosslink Capital.
Suki’s ambient clinical intelligence turns doctor-patient conversations into documentation, coding and other workflow output, and is used by more than 450 healthcare organisations. Why it matters: ambient scribing has become one of healthcare AI’s clearest wins; the next phase is agents that handle the paperwork around the visit. Suki is betting that health-tech platforms will embed its agents rather than build their own.
Abby Care Raises US$82 Million Series C to Pay Family Caregivers
BY BLACKSOLVENT NEWS
San Francisco-based Abby Care raised an US$82 million Series C led byTransformation Capital, with new investors including CVS Health Ventures.
Abby Care trains and certifies family members to become paid caregivers for loved ones at home, using a clinically led, AI-powered platform. Why it matters: the U.S. faces a deep shortage of home-care workers, and family caregivers already do much of the work unpaid. Backing from health-plan investors suggests payers see this model as a cheaper, better alternative to institutional care.
Stand Raises US$70 Million Series C at a US$1 Billion Valuation
BY BLACKSOLVENT NEWS
San Francisco-based Stand raised a US$70 million Series C at a US$1 billion valuation, led by Saga Ventures, with participation from Lowercarbon, Eclipse, Equal Ventures, Inspired Capital and others.
Stand insures homes in high-risk areas — wildfire in California and hurricanes in Florida — using digital-twin simulations of each property to show owners exactly which fixes cut their risk and premium. It says it now insures more than US$10 billion of property, up from US$1 billion a year ago. Why it matters: as traditional carriers retreat from climate-exposed markets, physics-based underwriting could keep homes insurable.
Mueon Raises US$65 Million Series A for Modular AI Computing
BY BLACKSOLVENT NEWS
Portland, Oregon-based Mueon raised a US$65 million Series A led by Maverick Silicon, with participation from Intel Capital and others.
Mueon is building “Cubelets”, modular three-dimensional compute and memory building blocks designed to cut the cost of moving data between processors and memory in AI and hyperscale systems. Why it matters: like Salience, Mueon attacks the interconnect and packaging bottleneck rather than the chip itself — a growing category as AI racks hit power and density limits.
North.cloud Raises US$60 Million Series B to Automate Cloud and AI Spend
BY BLACKSOLVENT NEWS
New York-based North.cloud raised a US$60 million Series B led by PeakSpan Capital.
North provides a financial operating system for cloud, AI and data infrastructure spend, and says it is approaching US$2 billion in managed cloud spend. Why it matters: AI bills are now big enough to have their own CFO problem. Alongside Ramp’s round, North’s raise shows investors backing the software that tells companies whether AI is worth what it costs.
Dougs Raises €50 Million to Automate Accounting With AI Agents
BY BLACKSOLVENT NEWS
Lyon-based Dougs raised €50 million (approximately US$56 million) from existing investor Expedition Growth Capital, its second round after eight years of bootstrapping.
Dougs is a profitable, technology-led accounting and financial management platform for very small businesses in France, now deploying AI agents to handle bookkeeping. Why it matters: accounting for micro-businesses is high-volume, rules-based and ripe for automation. A profitable incumbent rebuilding itself around agents is a strong counterpoint to AI-native challengers.
Harmonic Security Raises US$50 Million Series B to Secure Workforce AI
BY BLACKSOLVENT NEWS
San Francisco- and London-based Harmonic Security raised an oversubscribed US$50 million Series B led by Crosspoint Capital Partners, bringing total funding to US$76 million.
Harmonic helps enterprises see and control how employees use AI tools, preventing sensitive data from leaking into third-party models. Why it matters: every company now has “shadow AI”. Security teams want to say yes to AI adoption without losing control of data — and that is exactly the budget Harmonic is targeting.
Even Healthcare Raises US$50 Million Series B to Rethink Hospital Economics
BY BLACKSOLVENT NEWS
Bengaluru-based Even Healthcare raised a US$50 million all-equity Series B led by existing investor Khosla Ventures, with Alpha Wave participating, at a valuation of roughly US$300 million, according to TechCrunch.
Even combines healthcare membership with its own hospitals and salaried doctors, aiming to align incentives around keeping members healthy rather than billing for procedures. Why it matters: India’s private healthcare is expensive and fragmented; vertically integrated managed care is a bold, capital-heavy bet. The money funds additional hospitals rather than another app.
Rabot Energy Raises US$50 Million Series B for a Home Virtual Power Plant
BY BLACKSOLVENT NEWS
Hamburg-based Rabot Energy raised a US$50 million Series B led by Endeit Capital.
Rabot offers dynamic electricity tariffs and energy-management software that connects home batteries, EV chargers and heat pumps into a virtual power plant. Why it matters: Europe’s grids need flexibility as renewables and electrification grow. Turning households into dispatchable capacity is cheaper than building new plants — and gives consumers a share of the value.
The forward-looking takeaway is that AI’s money is following the bottlenecks — and the bills. The week’s largest cheques went to chips, AI cloud, photonic interconnects and modular compute; right behind them came the software that tracks, controls and secures what companies spend on AI. Meanwhile, AI-native insurers, healthcare operators and assistants crossed the billion-dollar line on visible traction, not promises. For founders, the playbook is clear: own a hard technical bottleneck, or own the workflow where the money moves. Expect the next few weeks to bring more compute megadeals — and, with OpenAI reportedly racing to raise before Anthropic’s expected IPO, a sharper public-market test of what AI is really worth.
Written by Blaksolvent News
Research note: Deal facts were compiled from Crunchbase News, TechCrunch, Reuters, Bloomberg, Fortune, Axios Pro, Tech.eu, EU-Startups, SiliconANGLE, Tech Startups, YourStory and company press releases published October 12–20, 2026. Otter.ai’s US$320 million is repayable, non-equity financing and is excluded from the total; CMR Surgical’s roughly US$400 million is a strategic preferred equity investment by Stryker, subject to closing; Labelbox’s round (“more than US$100 million”) includes a credit facility and is counted at its US$100 million floor. Euro amounts are converted at the rate implied by reporting on Nouscom’s round (about US$1.125 per euro). Where a lead investor or round type was not named in public reporting, this is stated rather than inferred.